Saturday 17 October 2026 Export KMDA’s income statement to Excel — free account

Kamada Ltd.

KMDA Healthcare Drug Manufacturers Specialty & Generic

Kamada Ltd.’s revenue for fiscal 2025 (year ended December 2025) was $180.5 million, up 12.1% from fiscal 2024. In the quarter to June 2026, revenue grew 22.7%, EPS grew 23.1%, free cash flow grew 165.7% and total debt fell 38.8%, each against the same quarter a year earlier. Revenue growth for three consecutive years.

7.77 0.06 −0.77%

Follow KMDA

Alert me

Market cap: $451.7M
P/E: 20.4×
Fwd P/E: 0.0×
Dividend yield: 5.41%
F-score: 7/9
Altman Z: 3.33
Beneish M: −2.35
Dividend safety: 50/100

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	19.28	20.17	23.83	19.32
P/S ratio Full definition →		2.34	2.26	2.71	2.21
P/FCF ratio Full definition →		22.27	26.00	30.09	16.15
P/Operating CF Full definition →		39.21	53.79	(1,691.74)	23.52
P/B ratio Full definition →		1.54	1.51	1.90	1.58
Price to Tangible BV Full definition →		1.74	1.70	2.15	1.78
EV/Sales Full definition →		2.05	1.95	2.42	1.94
EV/EBITDA Full definition →		8.32	8.56	10.86	8.61
EV/Operating CF Full definition →		12.63	13.82	17.13	10.39
EV/FCF Full definition →		19.51	22.50	26.93	14.12
Quick Ratio Full definition →		2.24	2.28	1.90	2.29
Current Ratio Full definition →		4.03	4.07	3.33	4.06
Net Debt/EBITDA Full definition →		(5.31)	(8.92)	(5.79)	(4.78)
Debt/Assets Full definition →		2.81%	2.62%	2.78%	1.57%
Debt/Equity Full definition →		0.04	0.04	0.04	0.02
Asset Turnover Full definition →		0.48	0.48	0.48	0.51
Operating CF/Net income Full definition →		1.97	2.12	(0.07)	1.95
Capex/Depreciation Full definition →		(0.95)	(0.73)	(0.25)	(0.54)
Interest Coverage Full definition →		35.37	13.71	36.98	25.63
Research and Development Expense of Revenue Full definition →		5.61%	6.48%	4.82%	4.01%
Selling, General and Administrative Expense of Revenue Full definition →		19.83%	23.55%	22.06%	19.59%
Intangible Assets out of Total Assets Full definition →		0.08	0.08	0.08	0.08
Share Based Compensation of Revenue Full definition →		0.25%	1.03%	1.77%	1.31%
Graham Net Nets Full definition →		0.20	0.21	0.15	0.20
Graham Number Full definition →		6.04	6.06	5.88	6.31
Earnings Yield Full definition →		5.19%	4.96%	4.20%	5.18%
Free Cash Flow Yield Full definition →		4.49%	3.85%	3.32%	6.19%
Revenue per Share Full definition →		0.80	0.78	0.77	0.95
Operating CF per Share Full definition →		0.18	0.13	0.00	0.31
Capex per Share Full definition →		(0.06)	(0.05)	(0.02)	(0.04)
Free Cash Flow per Share Full definition →		0.12	0.08	(0.02)	0.28
Cash per Share Full definition →		1.22	1.31	1.24	1.21
Shareholders Equity per Share Full definition →		4.51	4.67	4.39	4.66
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		4.51	4.67	4.39	4.66
Free Cash Flow Full definition →		6.83	4.79	(1.26)	15.96
Working Capital Full definition →		144.90	145.68	139.46	150.42
Capital Expenditures Full definition →		(3.59)	(2.77)	(0.97)	(2.11)
Net Current Asset Value Full definition →		80.76	83.44	75.60	85.97
EV/EBIT Full definition →		12.89	13.42	17.35	13.35
Capex to Sales Full definition →		0.08	0.06	0.02	0.04
Price to Operating Income Full definition →		14.71	15.51	19.39	15.27
Other line items
Average Receivables Full definition →		28.09	29.88	37.27	38.89
Average Payables Full definition →		28.60	36.38	45.52	37.28
Average Inventory Full definition →		78.49	81.88	81.90	84.48
Average Assets Full definition →		364.21	375.48	379.06	375.67
Average Common Equity Full definition →		260.25	264.27	255.67	264.76

Show all line items

Columns are period end dates

Stockrow Weekly